NUVA - NuVasive, Inc.
| Previous Close | 73.77 |
| Open | 74.18 |
| Bid | 74.73 x 2200 |
| Ask | 74.77 x 800 |
| Day's Range | 73.99 - 75.07 |
| 52 Week Range | 43.51 - 75.07 |
| Volume | 337,822 |
| Avg. Volume | 486,371 |
| Market Cap | 3.9B |
| Beta (3Y Monthly) | 1.17 |
| PE Ratio (TTM) | 83.15 |
| EPS (TTM) | 0.90 |
| Earnings Date | Feb 18, 2020 - Feb 24, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 71.60 |
- Zacks
NuVasive (NUVA) Hits 52-Week High, Can the Run Continue?
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks
Myriad Genetics Reports Favorable Study Result on Prequel
Myriad Genetics (MYGN) posts breakthrough results on Prequel Prenatal Screen methodology, proving its superiority over traditional methods.
- Zacks
Boston Scientific's Watchman Implant Study Results Encourage
These study results are expected to be a major breakthrough for Boston Scientific's (BSX) Cardiovascular segment.
- Zacks
NuVasive Advances on Global Footprint Despite Pricing Woes
Within NuVasive's (NUVA) U.S. Spinal Hardware business, a strong uptick in case volume and tangible growth in the XLIF and ALIF franchises are major upsides.
- Zacks
Illumina Inks Deal With ArcherDX to Deliver NGS-Based IVD Kits
Under the contract, ArcherDX will develop IVD tests that will run on Illumina's (ILMN) NextSeq 550Dx System.
- Zacks
Haemonetics (HAE) Launches SafeTrace Tx in North America
Haemonetics (HAE) expands the transfusion management portfolio with SafeTrace Tx, the latest in its transfusion management software product line.
- Zacks
Smith & Nephew's JOURNEY II UK Knee System Executes Surgeries
The JOURNEY II UK development is expected to provide a major impetus to Smith & Nephew's (SNN) Orthopedics segment.
- Zacks
HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q3
Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.
- Zacks
Thermo Fisher Rides on New Product Suite and Global Growth
A series of product launches with better precision medicine initiatives aids Thermo Fisher's (TMO) performance.
- Zacks
ViewRay Allies With Two Majors in MR-Guided Radiation Therapy
ViewRay's (VRAY) collective investments from Elekta and Medtronic are conditioned to the consummation of an equity capital hike of at least $75 million.
- Zacks
CVS Health Set to Acquire Centene's IlliniCare Health Plan
CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.
- Zacks
Here's Why You Should Invest in ResMed (RMD) Stock Right Now
Investors continue to be optimistic about ResMed (RMD) on its stellar performance.
- Zacks
Intuitive (ISRG) at a 52-Week High: What's Driving the Stock?
Intuitive Surgical (ISRG) has been gaining from a series of positive developments of late.
- Zacks
3 Reasons Why NuVasive (NUVA) Is a Great Growth Stock
NuVasive (NUVA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks
Veeva Systems (VEEV) Q3 Earnings and Revenues Beat Estimates
Veeva (VEEV) gains from solid segmental contributions in fiscal third quarter, raises fiscal 2020 view.
- Zacks
Here's Why You Should Buy Tandem Diabetes (TNDM) Stock Now
Investor confidence in Tandem Diabetes (TNDM) stock is at a high, thanks to solid prospects.
- Zacks
Walgreens, UnitedHealthcare Team Up to Boost Medicare Services
Walgreens (WBA) partners with UnitedHealthcare to further strengthen the Medicare coverage for its customers.
- PR Newswire
NuVasive to Present at the 31st Annual Piper Jaffray Healthcare Conference
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 31st Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace in New York City on Wednesday, Dec. 4, 2019 at 1:00 p.m. EST / 10:00 a.m. PST.
- Zacks
NuVasive Gets FDA Nod for CoRoent Small Interlock System
NuVasive (NUVA) receives the FDA clearance for expanded use of its Interlock system for minimally disruptive spine surgery at multiple levels.
- Zacks
Henry Schein to Showcase New Dental Offerings at GNYDM
Henry Schein's (HSIC) suite of solutions, education, & social media activity featuring dental industry leaders to enable dental professionals to explore new options revolutionizing digital dentistry.
- Zacks
Myriad's BRACAnalysis Wins HBOC Risk Assessment Nod in Japan
The latest approval of Myriad Genetics' (MYGN) BRACAnalysis for HBOC risk assessment in Japan will further validate the superior standard of the BRACAnalysis Diagnostic System, globally.
- Zacks
Dexcom (DXCM) Hits a 52-Week High: What's Driving the Stock?
Dexcom (DXCM) gains from several positive developments.
- Zacks
Myriad Genetics' Test Added in Disease Activity Measure List
Myriad Genetics' (MYGN) Vectra test receives recognition, with the inclusion in the list of recommended disease activity measures for RA patients.
- Zacks
Hologic (HOLX) Set to Divest Medical Aesthetics Business
Hologic (HOLX) to sell off its medical aesthetics business to focus on other core segments.
- Zacks
NUVA or RMD: Which Is the Better Value Stock Right Now?
NUVA vs. RMD: Which Stock Is the Better Value Option?
